Selected Publications

  1. Huang* Y, Kypridemos* C, Liu J, Yujin L, Pearson-Stuttard J, Collins B, et al. Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health. Circulation Read
  2. Pearson-Stuttard* J, Kypridemos* C, Collins B, Mozaffarian D, Huang Y, Bandosz P, et al. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis. PLOS Medicine 2018;15:e1002551 Read
  3. Guzman-Castillo M, Ahmadi-Abhari S, Bandosz P, Capewell S, Steptoe A, Singh-Manoux A, et al. Forecasted trends in disability and life expectancy in England and Wales up to 2025: a modelling study. Lancet Public Health 2017;2:e307–13 Read 
  4. Masters R, Anwar E, Collins B, Cookson R, Capewell S. Return on investment of public health interventions: a systematic review. J Epidemiol Community Health 2017;71:827–34 Read
  5. Kypridemos C, Allen K, Hickey GL, Guzman-Castillo M, Bandosz P, Buchan I, et al. Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options. BMJ 2016;353:i2793 Read
  6. Kypridemos* C, Collins* B, McHale P, Bromley H, Parvulescu P, Capewell S, et al. Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK. PLOS Medicine 2018;15:e1002573 Read

Recent Publications

Public Health and Cardiovascular Disease Modelling

  1. Huang* Y, Kypridemos* C, Liu J, Yujin L, Pearson-Stuttard J, Collins B, et al. Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health. Circulation
  2. Pearson-Stuttard* J, Kypridemos* C, Collins B, Mozaffarian D, Huang Y, Bandosz P, et al. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis. PLOS Medicine 2018;15:e1002551
  3. Benjamin E, Virani S, Callaway C, Chang A, Cheng S, Chiuve S, Cushman M, Delling F, Deo R, de Ferranti S, Ferguson J, Fornage M, Gillespie S, Isasi C, Jiménez M, Jordan L, Judd S, Lackland D, Lichtman J, Lisabeth L, Liu S, Longenecker C, Lutsey P, Matchar D, Matsushita K, Mussolino M, Nasir K, O'Flaherty M, Palaniappan L, Pandey D, Reeves M, Ritchey M, Rodriguez C, Roth G, Rosamond W, Sampson U, Satou G, Shah S, Spartano N, Tirschwell D, Tsao C, Voeks J, Willey J, Wilkins J, Wu C, Alger H, Wong S, Muntner P. Heart Disease and Stroke Statistics-2018 Update Circulation 2018 (accepted 20/11/17)
  4. Awad S et al Forecasting the Burden of Type 2 Diabetes Mellitus in Qatar to 2050: A Novel Modeling Approach. Diab Res and Clin Prac 2017 pii: S0168-8227(16)31694-1. doi: 10.1016/j.diabres.2017.11.015. [Epub ahead of print]
  5. Niveen M.E. Abu-Rmeileh, Rula Ghandour, Awad Mataria, Sameera Awawda , Samer Jabr , Martin O'Flaherty. Time to act on diabetes mellitus prevention in the West Bank, oPt: Current and future direct cost of diabetes and its complications. Obesity Medicine 2017 6:18-22
  6. M Guzman Castillo, S Ahmadi-Abhari, P Bandosz, S Capewell, A Steptoe, A Singh-Manoux, M Kivimaki, MJ Shipley, E J Brunner,M O’Flaherty.Forecasting trends in disability and life expectancies in England and Wales to 2025: a modelling study. Lancet Public Health 2017 2: e307–13.
  7. S Ahmadi-Abhari, M Guzman Castillo, P Bandosz, M J Shipley, G Muniz-Terrera,A Singh-Manoux, M Kivimäki, ASteptoe, S Capewell, M O’Flaherty, E J Brunner.Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: a modelling study. BMJ 2017; 358 j2856 doi: (Published 05 July 2017)
  8. C Kypridemos, M Guzman-Castillo, L Hyseni, G L. Hickey, P Bandosz, I Buchan, S Capewell, M O’Flaherty. Estimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: an IMPACTNCD microsimulation study. BMJ Open 2017; e013791 Read
  9. J Pearson-Stuttard, P Bandosz, C Rehm, J Penalvo, L Whitsel, T Gaziano, Z Conrad, P Wilde, R Micha, F Lloyd-Williams, S Capewell, D Mozaffarian, M O’Flaherty. Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies; a modelling study.PLoS Medicine 2017. 1002311 Read
  10. J Pearson-Stuttard, P Bandosz, C Rehm, J Penalvo, L Whitsel, T Gaziano, Z Conrad, P Wilde, R Micha, F Lloyd-Williams, S Capewell, D Mozaffarian, M O’Flaherty. Comparing effectiveness of mass media campaigns vs. price reductions targeting fruit and vegetable intake on US CVD mortality and race disparities Am J Clinical Nutrition 2017 AJCN/2016/143925
  11. J L Penalvo; F Cudhea; R Micha; C D Rehm; A Afshin; P Wilde; M O'Flaherty; J Pearson-Stuttard; L Whitsel; T Gaziano; S Capewell; D Mozaffarian. The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities in the United States. BMC Medicine 2017, 15:208 DOI 10.1186/s12916-017-0971-9
  12. M Psota, P. Bandosz, E. Goncalvesova, M. Avdicova, M. Psenkova, M. Jaripeki, S. Capewell, M.O’Flaherty. Explaining the Decline in Coronary Heart Disease Mortality rates in the Slovak Republic between 1993-2008. PloS ONE 2018, PONE-D-17-23071R1
  13. C. Kypridemos, K. Allen, G Hickey, M.Guzman-Castillo, P Bandosz, I Buchan,S Capewell, M O’Flaherty. Is cardiovascular screening the best option for reducing future cardiovascular disease burden? A microsimulation study to quantify policy options. BMJ 2016; 353: i2793 Read
  14. J Pearson-Stuttard, M Guzman Castillo, C Kypridemos, Christodoulos, S Capewell, M O'Flaherty. Modelling future cardiovascular disease mortality in the United States: national trends and racial and ethnic disparities.CIRCULATION 2016; 133: 967-978 DOI: 10.1161/CIRCULATIONAHA.115.019904 Read
  15. K. Allen, J Pearson-Stuttard, W Hooton, P Diggle, S Capewell, M O’Flaherty.Potential of trans fats policies to reduce socio-economic inequalities in coronary heart disease mortality in England: cost-effectiveness modelling study. BMJ 2015;351:h4583 doi: Read
  16. Patricia V. L. Moreira, Alex Newton, Lariss, Galastri Baraldi, Jean-Claude Moubarac, Carlos Augusto Monteiro, Simon Capewell Martin O’Flaherty. Effects Of Reducing Processed Culinary Ingredients And Ultra-Processed Food In The Brazilian Diet: A Cardiovascular Modelling Study.Public Health Nutrition 2017, in press. ID PHN-RES-2016-1172.R2
  17. J Critchley, S Capewell, M O Flaherty et al Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: contributions from risk factor changes and treatments. Int J Cardiology 2016;208:150-61.doi: 10.1016/j.ijcard.2016.01.031. PMID: 26878275
  18. J Pearson-Stuttard, J Critchley, W Hooton, M Collins, M Guzman-Castillo, H Mason, S Capewell, M O’Flaherty. Cost Effectiveness Analysis Of Eliminating Industrial And All Trans Fats In England And Wales: Modelling Study.J Public Health 2016. ID JPH-16-0213.R1 Read
  19. M Guzman-Castillo, R Ahmed, N Hawkins, S Scholes, E Wilkinson, J Lucy,S Capewell, M O’Flaherty. The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study. BMJ Open, 2015;5:e006070.doi:10.1136/bmjopen-2014-006070 (
  20. C Koopman, I.Van.Dis, M Verschuren, P. Engelfriet, E. Heintjes, A. Blokstra, D.Deeg, M.Visser, M.L.Bots, M.Oflaherty, S. Capewell C.H.Vaartjes,Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007. PloS ONE 2016 16-14283R2 PMID: 27906998
  21. K Allen, DOS. Gillespie, , M Guzman-Castillo, , PJ. Diggle, S Capewell,M O'Flaherty, Future trends and inequalities in premature coronary deaths in England: Modelling study. Int J Cardiology 2016; 203: 290–297. doi:10.1016/j.ijcard.2015.10.077
  22. O'Flaherty, M.; Bandosz, P.; Critchley, J.; et al. Euroheart II Steering Grp. Exploring potential mortality reductions in 9 European countries by improving diet and lifestyle: A modelling approach (vol 207, pg 286, 2016)Int J Cardiology 2016;214: 536-536.
  23. C.Kypridemos, P.Bandosz, G.Hickey, M.Guzman-Castillo, K.Allen, I. Buchan, S. Capewell, M O’Flaherty. Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991 - 2012: A Modelling Study. PLoS ONE 2015 10(4): e0123112. doi:10.1371/journal. pone.0123112
  24. J Hotchkiss, C Davies, R. Dundas, N Hawkins, P Jhund, S Scholes, M. Bajekal, M. O’Flaherty, J Critchley, A Leyland, S Capewell. Explaining Trends in Scottish Coronary Heart Disease Mortality between 2000 and 2010: Socioeconomic Analysis using the IMPACTsec Model. A Retrospective Analysis using Routine Data. BMJ 2014; 348: g1088 DOI: 10.1136/bmj.g1088
  25. Kirk Allen; Chris Kypridemos; Lirije Hyseni; Anna B Gilmore; Peter Diggle; Margaret Whitehead; Simon Capewell; Martin O’Flaherty The effects of maximising the UK's Tobacco Control Score on inequalities in smoking prevalence and premature coronary heart disease mortality: a modelling study. BMC Public Health 2016; 16(1):292
  26. Islek D, Sozmen K, Unal B, Guzman-Castillo M, Vaartjes I, Critchley J, Capewell S, O’Flaherty M. Estimating the potential contribution of stroke treatments and preventative policies to reduce the stroke and ischemic heart disease mortality in Turkey up to 2032: a modelling study. BMC Public Health.2016, 16:46 DOI: 10.1186/s12889-015-2655-8 URL:
  27. L Björck, A Rosengren, Anna Winkvist, S Capewell, P Bandosz, K Boman, M Adiels, M. Guzman-Castillo, M. O’Flaherty, I Johansson.Changes in dietary fat intake and projections for coronary heart disease mortality in Sweden: a simulation study PLoS ONE 2016; 11(8): e0160474
  28. Sahan C, Zosmen K, Unal B, O’Flaherty M, Crtichley J. Potential benefits of Healthy Food and Lifestyle Policies for Reducing Coronary Heart Disease Mortality in Turkish Adults by 2025: A Modelling Study. BMJ Open 2016 6: e011217
  29. O’Flaherty M, Guzman M. Keeping Public Health Clean: Food Policy Barriers and Opportunities in the Era of the Industrial Epidemics AIMS Public Health, 2016 3 (2): 228-234 DOI: 10.3934/publichealth.2016.2.228
  30. Saidi O, Malloiuche D, O’Flaherty M, Ben Masour N, Besdah L, Skhiri H, Ben Rodhane H Assessment of cardiovascular risk in Tunisia – applying the Framingham risk score to national survey data.. BMJ Open 2016;6:e009195. doi:10.1136/bmjopen-2015-009195
  31. J Pearson-Stuttard, , S Capewell. M O’Flaherty, Quantifying the socio-economic benefits of reducing industrial dietary trans fats: modelling study. PLoS ONE 2015; 10 (8) e0132524
  32. B Collins, S Capewell, M O'Flaherty, et al. Modelling the Health Impact of an English Sugary Drinks Duty at National and Local Levels. PLoS ONE 2015; 10 (6) e0130770 DOI: 10.1371/journal.pone.0130770
  33. Capewell S. IMPACT Coronary Heart Disease Policy Model and Prevention Policies. Research Excellence Framework Impact Case Study, University of Liverpool, UoA2.
  34. M Collins, H Mason, M O’Flaherty, M Guzman-Castillo, J Critchley, S Capewell.An economic evaluation of salt reduction policies to reduce cardiovascular disease in England: a policy modelling study.Value in Health 2014; 17: (5): 517-524. DOI: 10.1016/j.jval.2014.03.1722
  35. J Hughes, Z Kabir, K Bennett, J Hotchkiss; F Kee; A Leyland, C Davies, P Bandosz, M. Guzman-Castillo, M O'Flaherty, S Capewell, J Critchley. Modelling Future Coronary Heart Disease Mortality To 2030 In The British IslesPLOS ONE 2015 DOI: 10.1371/journal.pone.0138044
  36. L Björck, M. O’Flaherty, G Lappas, K Bennett, S Capewell, A Rosengren.Decline in coronary mortality in Sweden between 1986 and 2002: comparing contributions from primary and secondary preventionPLoS ONE 2015; 10 (5) e0124769 DOI: 10.1371/journal.pone.0124769
  37. M D. Huffman, H Ning, C M. Shay, Earl S. Ford, D M. Lloyd-Jones, M Guzman, M O’Flaherty, S Capewell. Quantifying Options for Reducing Coronary Heart Disease Mortality by 2020. Circulation 2013; 127: 2477. doi: 10.1161/CIRCULATIONAHA.112.000769
  38. D Gillespie, K Allen, M Guzman Castillo, P Bandosz, V Schmid, P Diggle, S Capewell & M O’Flaherty. The health equity and effectiveness of policy options to reduce dietary salt intake in England: policy forecast. PLoS ONE 2015; 10 (7) e0134064 doi: 10.1371/journal.pone.0127927
  39. S Scholes, M Bajekal, P Norman, M O’Flaherty, N Hawkins, M Kivimäki, S Capewell, R Raine. Quantifying Policy Options for Reducing Future Coronary Heart Disease Mortality in England: A Modelling Study.PLoS ONE 2013; 8(7):e69935. doi:10.1371/journal.pone.0069935
  40. M Bajekal, S Scholes, H Love, N Hawkins, M O’Flaherty, R Raine, S Capewell.Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Medicine 2012; 9(6): e1001237. doi:10.1371/journal.pmed.1001237. PMID: 22719232
  41. P Bandosz, M O' Flaherty, W Drygas, M Rutkowski, J Koziarek, B Wyrzykowski, K Bennett, T Zdrojewski & S Capewell. Analysing the decline in coronary heart disease mortality in Poland after socioeconomic transformation. A modeling study. BMJ 2012; 344:d8136 doi: 10.1136/bmj.d8136 PMID: 22279114
  42. N Hawkins, M Bajekal, S Scholes, H Love, M O’Flaherty, R Raine, S Capewell.Community care in England: reducing socioeconomic inequalities in heart failure. Circulation. 2012; 126: 1050-57; doi:10.1161/CIRCULATIONAHA.111.088047 PMID: 22837162
  43. P. Bandosz, M Guzman-Castillo, S Capewell, T Zdrojewski, J Critchley, M Rutkowski,M O’Flaherty. A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: a modelling study.Int J Cardiology 2015; 185: 313–319. DOI:
  44. M D. Huffman, S Capewell, H Ning, C M. Shay, Earl S. Ford, D M. Lloyd-Jones,Cardiovascular Health Behavior and Health Factor Changes (1999-2008) and Projections to 2020: Results from the National Health and Nutrition Examination Surveys(NHANES). Circulation 2012; 125: 2595-2602. DOI:10.1161/CIRCULATIONAHA.111.070722 PMID: 22547667
  45. P Moreira PVL, Baraldi LG, Moubarac J-C, Monteiro CA, Newton A,Capewell S, O’Flaherty M. Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach.PLoS ONE 2015 10(2): e0118353. doi:10.1371/journal.pone.0118353
  46. L. Webber, O T. Mytton, A. D. M. Briggs, J. Woodcock, P. Scarborough, K. McPherson, S. Capewell. The Brighton declaration: the value of non-communicable disease modelling in population health sciences,Eur J Epidemiology. 2014, 29 (12): 867-870, doi: 10.1007/s10654-014-9978-0
  47. P Barton, L Andronis, A Briggs, K McPherson, S Capewell.Effectiveness and cost-effectiveness of cardiovascular disease prevention in whole populations: modelling study.BMJ 2011; 343:d4044: doi:10.1136/bmj.d4044 PMID: 21798967
  48. M Guzman Castillo, D Gillespie, K Allen, P Bandosz, V Schmid, S Capewell & MO’Flaherty. Future declines of Coronary Heart Disease mortality in England and Wales could counter the burden of population ageing.PLOS ONE 2014;9: 6 e99482. DOI: 10.1371/journal.pone.0099482
  49. Meredith L. Wilcox, Helen Mason, Fouad M. Fouad, Samer Rastam, Radwan al Ali, Timothy F. Page, Simon Capewell, Martin O’Flaherty, Wasim Maziak. Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010–2020. Int J Public H 2014;
  50. Saidi, O; O'Flaherty, M; Mansour, N Ben; Aissi, W; Lassoued, O; Capewell, S; Critchley, J A; Malouche, D; Romdhane, H Ben Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model. BMC Public Health 2015; 15:1416. DOI:10.1186/s12889-015-1416-z
  51. M Pereira, A Azevedo, N Lunet, H Carreira, M O’flaherty, S Capewell, K Bennett. Explaining the decline in coronary heart disease mortality in Portugal between 1995 and 2008. Circulation CQO 2013; 6 (6) 634-9. DOI: 10.1161/CIRCOUTCOMES.113.000264
  52. N Abu-Rmeileh, A Shoaibi1,M O’Flaherty,S Capewell,A Husseini. Analysing falls in coronary heart disease mortality in the West Bank between 1998 and 2009. BMJ Open 2012; 2:e001061 doi:10.1136/bmjopen-2012-001061 PMID: 22923626
  53. Couch P, Ainsworth, J; Carruthers, E; Couch, P; Green, N; O'Flaherty, M; Sperrin, M; Williams, R; Asghar, Z; Capewell, S; Buchan, I. e-Labs and the Stock of Health Method for Simulating Health Policies. Studies Health Technol Inform 2013: , 192, 288-292. eScholarID:205910
  54. B Unal, K Sozmen, H Arik, G Gerceklioglu, D Altun, H Simsek, S Doganay, Y Demiral, O Aslan, K Bennet, M O´Flaherty, S Capewell and J Critchley. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health 2013; 13:1135. DOI: 10.1186/10.1186/1471-2458-13-1135
  55. Mason H, Critchley J, Capewell S et al. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries. PLoS ONE 2014 9 (1) e84445 DOI: 10.1371/journal.pone.0084445
  56. Thorolfsdottir, RB; Andersen K, Aspelund T, Gudnason V, Thorsson B, Critchley J,Capewell S. Population assessment of future trajectories in coronary heart disease mortality. PLoS ONE 2014; 9: e0085800. DOI: 10.1371/journal.pone.0085800
  57. Al-Quwaidhi AJ, Pearce MS, O'Flaherty M, Sobngwi E, Critchley JA. Trends and future projections of the prevalence of adult obesity in Saudi Arabia during 1992 – 2022. Eastern Mediterranean Health Journal 2014 20(10):589-95.
  58. Aluwaihidi A, Pearce N, O´Flaherty M, Sobngwia E, Critchley J Obesity and type 2 diabetes mellitus: a complex association. Saudi Journal of Obesity 2014 1(2): 49-56
  59. Al-Quwaidhi A, Pearce M, Sobngwia E, Critchley J, O'Flaherty M, Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation Diabetes Atlas and other modelling studies. Diabetes Research and Clinical Practice 2014 103(3): 496–503
  60. Z Kabir, ,I J Perry ,M O Flaherty ,J Critchley , S Capewell; K Bennett .Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006. Int J Cardiol 2013: 168: 2462 – 2467. DOI: 10.1016/j.ijcard.2013.03.007
  61. N Hawkins M Bajekal, S Scholes, H Love, M O’Flaherty, R Raine, S Capewell.The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease. Circulation CQO 2013; 6 (2): 208-16.DOI:10.1161/CIRCOUTCOMES.111.000058 (Epub 2013 Mar 12)
  62. Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982-2006: analytical study. PLoS ONE 2013 8(3): e59608. doi:10.1371/journal.pone.0059608
  63. N. Abu-Rmeileh, A Shoaibi1,M O’Flaherty,S Capewell, A Husseini.Preventing type 2 diabetes among Palestinians: comparing five future policy scenarios. BMJ Open-2013-13-12.
  64. M Psota, S Capewell, M O’Flaherty, E Gonçalvesová. The causes of changes in coronary heart disease mortality rates using the IMPACT model: a systematic review (Príčiny zmien v úmrtnosti na ischemickú chorobu srdca podľa modelu IMPACT: systematický prehľad). Cardiology Letters 12/2013; 22(6):449-458.
  65. O. Saidi, N. Ben Mansour, M. O’Flaherty,S. Capewell,J. Critchley, H. Ben Romdhan. Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009. PLoS ONE 2013 8(5): e63202. doi:10.1371/journal.pone.0063202
  66. Al Ali R, Mzayek F, Rastam S, M Fouad F, O'Flaherty M, Capewell S, Maziak W Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health 2013, 13:507 doi:10.1186/1471-2458-13-507
  67. S Rastam, R Al Ali, W Maziak,F Mzayek, F M. Fouad, M O'flaherty, S Capewell.Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006. BMC Public Health 2012 2012;12(1):754. DOI: 10.1186/1471-2458-12-754 PMID: 22958443
  68. E S. Ford, S Capewell. Proportion of the Decline in CVD due to Prevention versus Treatment: Public Health versus Clinical Care. Annual Review of Public Health 2011,32: 5-22. DOI: 10.1146/annurev-publhealth-031210-101211 PMID: 21417752
  69. H C. Wijeysundera, M Machado, F Farahati, X Wang,W Witteman, G van der Velde, J V. Tu, D S. Lee, S G. Goodman, R Petrella, M O’Flaherty, M Krahn, S Capewell. Association of Temporal Trends in Risk Factors and Treatment Uptake with Coronary Heart Disease Mortality, 1994-2005. JAMA 2010; 303[18]:1841-47 (doi:10.1001/jama.2010.580). PMID: 20460623
  70. J Bruthans, R Cifkova, Věra Lánská, M O´Flaherty, JA Critchley, JHolub, P Janský,
  71. J Zvárová, S Capewell. Explaining the decline in coronary heart disease mortalityin the Czech Republic between 1985 and 2007. European Journal of Preventive Cardiology 2014; 21 (7); 829-839. DOI: 10.1177/2047487312469476
  72. H C. Wijeysundera, M Machado, J V. Tu, D S. Lee, S G. Goodman, R Petrella,M O’Flaherty, S Capewell, M Krahn. Achieving Quality Indicator Benchmarks and Potential Impact on Coronary Heart Disease Mortality.Canadian J Cardiology 2011; 27 (5): 27 (6) 756-762DOI: 10.1016/j.cjca.2011.06.005 PMID: 21920697
  73. L Björck, A Rosengren, K Bennett, G Lappas, S Capewell. Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains. J Internal Med 2011; 269(4);452-467.doi: 10.1111/j.1365-2796.2010.02339.x. Epub 2011 Jan 13. PMID: 21205025
  74. H N Gouda, J Critchley, J Powles and S Capewell. Why choice of metric matters in public health analyses: a case study of the attribution of credit for the decline in coronary heart disease mortality in the US and other populations. BMC Public Health 2012, 12: 88 doi:10.1186/1471-2458-12-88. PMID: 21975324
  75. G Flores-Mateo, M Grau, M O’Flaherty, R Ramos, R Elosua, C Violan-Fors, M Quesada, R Martí, J Sala, J Marrugat, S Capewell. Analysing the Coronary Heart Disease Mortality Decline in a Mediterranean Population: Spain 1988 – 2005. Rev Esp Cardiol. 2011;64(11):988–996. doi:10.1016/j.rec.2011.05.035 PMID: 21962958
  76. Ainsworth, J; Carruthers, E; Couch, P; Green, N; O'Flaherty, M; Sperrin, M; Williams, R; Asghar, Z; Capewell, S; Buchan, I . IMPACT: A generic tool for modelling and simulating public health policy. Methods Inf Med. 2011;50(5):454-63. Epub 2011 Sep 14. DOI: 10.3414/ME11-02-0006 PMID: 21915434
  77. J Hughes, F Kee, M O’Flaherty, J Critchley, M Cupples, S Capewell, and K Bennett . Modelling Coronary Heart Disease Mortality in Northern Ireland between 1987 and 2007 - Broader Lessons for Prevention. Eur J Prev Cardiol. 2013 Apr;20(2):310-21. DOI: 10.1177/2047487312441725 PMID: 22403395
  78. S Capewell, ES Ford, JB Croft, JA Critchley, KJ Greenlund, DR Labarthe. Cardiovascular risk factor trends in the US population and options for reducing future CHD mortality. WHO Bulletin 2010; 88; 120-130. PMID: 20428369
  79. F Young, S Capewell. ES Ford, JA Critchley. Coronary mortality declines in the USA between 1980 and 2000: quantifying the contributions from primary and secondary prevention. Am J Preventive Medicine 2010; 39 (3) 228 – 234.DOI: 10.1016/j.amepre.2010.05.009 PMID: 20709254
  80. H C. Wijeysundera, M Machado, X Wang4, G van der Velde, N Sikich, W Witteman, J V. Tu, D S. Lee, S G. Goodman, R Petrella, M O’Flaherty, S Capewell, M Krahn. Cost-effectiveness of Specialized Multi-disciplinary Heart Failure Clinics in Ontario, Canada. Value in Health 2010;13(8):915-21. doi: 10.1111/j.1524-4733.2010.00797.x. PMID: 21091970
  81. T Aspelund, V Gudnason, BT Magnusdottir,K Andersen G Sigurdsson, B Thorsson, L Steingrimsdottir, J Critchley, K Bennett, M O’Flaherty, S Capewell.Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006.PLoS ONE 2010 5(11): e13957. doi:10.1371/journal.pone.0013957. PMID: 21103050
  82. Buchan I, Ainsworth J, Carruthers E, Couch P, O'Flaherty M, Smith D, Williams R, Capewell S. IMPACT: A generalisable system for simulating public health interventions. Studies Health Technol Inform. 2010;160(Pt 1):486-90.PMID: 20841734
  83. Björck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the Decreasing Coronary Heart Disease Mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30; 1046-9. PMID: 19141562
  84. S Capewell, DK Hayes, ES Ford, JA Critchley, JB Croft, KJ Greenlund, DR Labarthe. Life-years gained from modern treatments and population risk factor changes US, 1980–2000. Am J Epid 2009. PMID: 19541856 doi:10.1093/aje/kwp150

Public Health and Prevention Policy, Advocacy and Editorials

  1. S Capewell, M O’Flaherty, ES Ford, JA Critchley. Potential reductions in United States coronary heart disease mortality by treating more patients.Am J Cardiology 2009; 103: 1703-1709. PMID: 19539079
  2. Palmieri L, Bennett K, Giampaoli S, and Capewell S. Explaining the Decrease in Coronary Heart Disease Mortality in Italy between 1980 and 2000 Am J Public Health 2009, 10.2105/AJPH.2008.147173. PMID: 19608958
  3. Jun CHENG, Dong ZHAO, Zhechun ZENG, J A CRITCHLEY, Jing LiU, Wei WANG, Jiayi SUN, S CAPEWELL. The Impact of Demographic and Risk Factor Changes on Coronary Heart Disease Deaths in Beijing, 1999-2010. BMC Public Health 2009, 9: 30. PMID: 19159492
  4. T.E.Kottke, D.A.Faith, C.O Jordan, N.P. Pronk, T.Randal, S Capewell. The Comparative Effectiveness of Heart Disease Prevention and Treatment Strategies. Am J Preventive Med 2009; 36; 82-88. PMID: 19095166
  5. K Bennett, Z Kabir, M Barry, L Tilson, D Fidan, E Shelley, S Capewell. Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010. Value in Health 2009; 12: 10-15 PMID: 19040564
  6. Z Kabir, G Connolly; L Clancy, H Koh; S Capewell. Reduced CHD deaths attributable to decreased smoking prevalence in Massachusetts, 1993-2003. Am J Public H 2008; 98: 1468-1469. DOI: 10.2105/AJPH.2007.129924
  7. ES Ford, UA Ajani, JB Croft, JA Critchley, DR Labarthe, TE Kottke, WH Giles, S Capewell. Explaining the Decrease in US deaths from Coronary Disease,1980 -2000. New England Journal of Medicine 2007; 356: 2388-2398. PMID: 17554120
  8. SL Hardoon, PH Whincup, LT Lennon, SG Wannamethee, S Capewell, RW Morris. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population based study. PMID: 18212284 Circulation 2007; 117: 598-604.
  9. Z Kabir, K Bennett, E Shelley, Be Unal, J A Critchley and S Capewell. Comparing primary prevention with secondary prevention to explain decreasing CHD death rates in Ireland, 1985-2000. BMC Public Health. 2007; 7:117. DOI: 10.1186/1471-2458-7-117
  10. Z Kabir, K Bennett , J Critchley, S Capewell. Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland? Eur J Epid 2007.22; 83-89. DOI 10.1007/s10654-006-9098-6
  11. D Fidan, B Unal, J Critchley, S Capewell. Economic analysis of treatments reducing CHD mortality in England and Wales, 2000-2010. QJM 2007, [May] 100(5): 277- 289. PMID: 17449875
  12. Z Kabir, K Bennett , J Critchley, S Capewell. Life-Years Gained From Population Risk Factor Changes And Modern Cardiology Treatments In Ireland. Eur J Public H. 2007 17:193-198. DOI: 10.1093/eurpub/ckl090 Public Health & Prevention Policy, Advocacy, & Editorials
  13. S Capewell, P Cairney & A Clarke. Should action take priority over further research on public health? BMJ 2018; 360:k292 doi: Read
  14. R Masters, E Anwar, B Collins, R Cookson, S Capewell. The return on investment of public health interventions: a systematic review. J Epidemiol Community Health 2017; 71 (8): 827-834 doi:10.1136/jech-2016-208141
  15. Ashkan Afshin, Renata Micha, Michael Webb, Simon Capewell, Laurie Whitsel, Adolfo Rubinstein, Dorairaj Prabhakaran, Marc Suhrcke, and Dariush Mozaffarian.Chapter 6. Effectiveness of Dietary Policies to Reduce Noncommunicable Diseases 101-120. In: Prabhakaran, D., S. Anand, T. A. Gaziano. J.-C. Mbanya, Y. Wu, and R. Nugent. 2017. Cardiovascular, Respiratory, and Related Disorders. Disease Control Priorities, (3rd edition), Vol 5. Washington, DC: World Bank. doi:10.1596/978-1-4648-0518-9.
  16. Lirije Hyseni, Helen Bromley, Chris Kypridemos, Martin O’Flaherty, Ffion Lloyd-Williams, Maria Guzman-Castillo, Jonathan Pearson-Stuttard, Simon Capewell. Systematic review of dietary trans-fat reduction policies: evidence for an effectiveness hierarchy? WHO Bulletin 2017 Dec 1; 95(12): 821–830G.Published online 2017 Oct 19. doi: 10.2471/BLT.16.189795
  17. Chris Kypridemos, Brendan Collins, Paula Parvulescu, Rachael Gosling, Simon Capewell, Martin O’Flaherty. Cost-Effectiveness And Equity Of NHS Health Checks In Liverpool. Report to Liverpool City Council. April 2017.
  18. S Capewell & CF Dowrick. Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors: Is Behavioral Counselling necessary? Editorial. JAMA Published Online: July 11, 2017. doi:10.1001/jamainternmed.2017.1979
  19. S Capewell & F Lloyd Williams. The role of the Food Industry in Health: Lessons from Tobacco? British Medical Bulletin 2018 (in press); ID BMB-2017-029
  20. S Capewell & A Capewell. An Effectiveness Hierarchy of Preventive Interventions: neglected paradigm or self-evident truth? Journal of Public Health 2017. 1-9 DOI 10.1093/pubmed/fdx055
  21. L Hyseni, A Elliot Green, F Lloyd-Williams, M O’Flaherty, C Kypridemos, R McGill, L Orton, H Bromley, F Cappuccio, S Capewell. Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?. PLOS ONE,2017 12(5). doi:10.1371/journal.pone.0177535
  22. Anon. Healthy Lives and Fairer Futures. A call to action. Committee of the Faculty of Public Health in Scotland. Oct 2017
  23. H Rutter & S Capewell. Burden of obesity costs UK more than £27 billion per year PH Today Spring 2017:7
  24. S Capewell. Are nanny states healthier states? BMJ 2016;355:i6341 doi: 10.1136/bmj.i6341
  25. C Cerny & S Capewell. Many hands are making lite work. PH Today Spring 2017: 16
  26. A Afshin, J Penalvo, L Delgobbo, JM Silva, M Michaelson, M O’Flaherty, S Capewell, G Danaei, D Mozaffarian. The prospective impact of food pricing on improving dietary consumption: a systematic review and meta-analysis. PLoS ONE 2017 12(3): e0172277. doi:10.1371/journal.pone.0172277
  27. S Capewell & F Lloyd Williams. Promotion of healthy food and beverage purchases: are subsidies and consumer education sufficient? (Comment) Lancet Public Health 2017 Published online: January 24, 2017
  28. S Capewell & C Kypridemos. Socioeconomic inequalities in dietary sodium intake: upstream vs downstream interventions. Editorial. Am J Public Health 2017; 107(4): 499–500.
  29. A B Gilmore & S Capewell. Should we welcome food industry funding of public health research? NO. BMJ 2016;353:i2161 doi: 10.1136/bmj.i2161
  30. L Hyseni, M Atkinson, H Bromley, L Orton, F Lloyd- Williams, R McGill, S Capewell. The effects of policy actions to improve population dietary patterns and prevent diet related non-communicable diseases: scoping review.Eur J Clinical Nutrition 2017; 71: 694 – 711.
  31. J Boulton, K Hashem, K Jenner, F Lloyd Williams, Capewell S. How much sugar is hidden in drinks marketed to children? A survey of fruit juices, juice drinks and smoothies. BMJ OPEN 2016; 6 (3): e010330.
  32. A Newton; F Lloyd-Williams; H Bromley; S Capewell. Food for thought? Potential conflicts of interest in academic experts advising government and charities on dietary policies BMC Public Health 2016; 16: 735
  33. F Lloyd-Williams & S Capewell. Editorial. Selling a sugar tax: the sweet smell of success? Community Dental Health (2016) 33, 174–176
  34. SSM ECR Subcommittee (2015) and S Capewell (SSM President). Academic Careers: What do Early Career Researchers Think? JECH 2016.
  35. Lloyd-Williams, F, Elliott Green A, Hyseni L, Bromley, H; Capewell, S. "Sugar Sweetened Beverages Coverage in the British Media – An Analysis of Public Health Advocacy versus Pro-Industry Messaging" BMJ Open 2016 ID bmjopen-2016-011295
  36. McKee M, Capewell S. Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ 2015;351:h4863. doi:10.1136/bmj.h4863
  37. S Capewell; M McCartney; W Holland. Invited debate: NHS Health Checks--a naked emperor? J Public Health 2015 37 (2): 187-192. doi: 10.1093/pubmed/fdv063
  38. S. Capewell, M. McCartney, W. Holland. Invited debate. NHS Health Check: an innovative component of local adult health improvement and well-being programmes in England. Response to Waterall et al. J Public Health 2015 37 (2): 185-186. doi: 10.1093/pubmed/fdv066
  39. R Hobbs; M Banach; D Mikhailidis; A Malhotra; S Capewell. Is statin modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate BMC Medicine 2016 14:4 DOI: 10.1186/s12916-016-0550-5
  40. R Encarnação, H Bromley, F Lloyd Williams, S Capewell. Obesity prevention strategies: Could food or soda taxes improve health? J Royal College of Physicians of Edinburgh. 2016: 46: 32-38. DoI: 10.4997/JRCPE.2016.109
  41. F Lloyd-Williams, H Bromley, L Orton, C Hawkes, D Taylor-Robinson, M O’ Flaherty, R McGill, E Anwar, L Hyseni, M Moonan, M Rayner, S Capewell. Smorgasbord or symphony? Assessing public health nutrition policies across 30 European countries using a novel framework. BMC Public Health.2014, 14:1195. DOI: 10.1186/1471-2458-14-1195
  42. McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O’Flaherty M, Taylor-Robinson D, Guzman-Castillo M, Gillespie D, Moreira P, Allen K, Hyseni L, Calder N, Petticrew M, White M, Whitehead M, Capewell S. Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health 2015; 15:457 DOI: 10.1186/s12889-015-1781-7
  43. Ghandour, R, Shoaibi, A, Khatib, R, Abu Rmeileh, N, Unal, B, Sozmen, K, Kilic, B,Fouad, F, Al Ali, R, Ben Romdhane, H, Aissi, W, Ahmad, B, Capewell, S, Critchley, J Husseini, A. Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four eastern Mediterranean countries. Int J Public Health 2015; 60: S73-S81. Suppl 1. DOI: 10.1007/s00038-014-0569-3
  44. Sozmen, K, Unal, B; Saidi, O; Ben Romdhane, H; Abu-Rmeileh, N; Husseini, A ; Fouad, F ; Maziak, W; Bennett, K; O'Flaherty, M; Capewell, S; Critchley, J. Cardiovascular risk factor trends in the Eastern Mediterranean region: evidence from four countries is alarming. Int J Public Health 2015; 60: S3-S11 Suppl 1. DOI: 10.1007/s00038-014-0610-6
  45. Sozmen, K; Unal, B; Capewell, S; Critchley, J; O'Flaherty, M. Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach. Int J Public Health 2015; 60; S13-S21 Supplement: 1 DOI: 10.1007/s00038-014-0622-2
  46. S Capewell: Spending NHS funds on weight management services—naughty or NICE? BMJ Blog 20
  47. K M Hashem, S Pombo-Rodrigues, S Capewell. Reducing sodium in the global food supply to reduce population burden of cardiovascular disease. Current Cardiovascular Risk Reports. February 2015, 9:7 DOI: 10.1007/s12170-014-0435-0
  48. O’Flaherty, M. The last Public Health Practitioner: a dystopian tale. Lancet 2015 Volume 386, No. 9994, p643–644.
  49. A Malhotra, A Apps, S Capewell. Maximising the benefits and minimising theharms of statins. Prescriber Jan 2015.
  50. S Capewell. Personal View. Sugar Sweetened Drinks Should Carry Obesity Warnings. BMJ 2014; 348: g3428. DOI: Read
  51. T Stephenson, K Bhui, S Capewell, V Chitre, A Malhotra, M Larvin, M Lean, S Lacey, D Rowbotham, R Pryke, J Wass. M Wiseman. Measuring Up: the medical profession’s prescription for the nation’s obesity crisis. Academy of Medical Royal Colleges, London. February 2013.
  52. Kypridemos, C; O'Flaherty, M; Capewell, S. Fruit and vegetable consumption and non-communicable disease: time to update the '5 a day' message? J Epidemiology & Community Health 2014: 68 (9) 799-800. DOI: 10.1136/jech-2014-20398
  53. F P Cappuccio & S Capewell. Facts, issues and controversies in salt reduction for the prevention of cardiovascular disease. Functional Food Reviews, 2015: 7, (1):41–61. DOI 10.2310/6180.2015.00005
  54. Bonita R, Magnusson R, Bovet Pl, Zhao D, Malta D C, Geneau R, Suh Il, Thankappan K R, Varghese C, Shin Hai-Rim , Han Tieru , McKee M , Hospedales J, Galea G, de Courten M, Capewell S, Beaglehole R, for the Lancet NCD Action Group. Country actions to meet UN commitments on NCDs: a stepwise approach. Lancet 2013; 381; 9866: 575-584. DOI: 10.1016/S0140-6736(12)61993-X
  55. Anon. NICE Public Health Guidance: Prevention of cardiovascular disease at population level. 2010, reviewed and updated in 2014:
  56. M O’Flaherty, G Flores-Mateo, K Nnoaham, F Lloyd-Williams, S Capewell. Estimating potential cardiovascular mortality reductions with different food policy options in the UK. WHO Bulletin 2012, 90: 522-531. Doi:10.2471/BLT.11.092643 PMID: 22807598
  57. S Capewell & M O’Flaherty. Mortality falls can rapidly follow population-wide risk factor changes. Lancet, 2011; 378: 752-753. PMID: 21414659
  58. D Mozaffarian & S Capewell. United Nations dietary policies to prevent cardiovascular disease. Modest diet changes could halve the global burden. BMJ 2011; 343: d5747 PMID: 21933831
  59. Cappuccio, F P.; Capewell, S; He, F J. Salt: The Dying Echoes of the Food Industry. American Journal of Hypertension 2014; 27 (2): 279-281. DOI: 10.1093/ajh/hpt216
  60. F P Cappuccio, S Capewell, P Lincoln, K McPherson. Population salt reduction to prevent cardiovascular disease: identifying policy options. BMJ 2011; 343: d4995 PMID: 21835876
  61. S Capewell, K Andersen. The ESC goes global: Policies to prevent all chronic disease. Eur Heart J 2011; 32: 2333; doi:10.1093/eurheartj/ehr271. PMID:22066144
  62. Ford E, Capewell S. Trends in Total and Low-Density Lipoprotein Cholesterol among U.S. Adults: Contributions of Changes in Dietary Fat Intake and Use of Cholesterol-Lowering Medications. PLoS ONE 2013 PONE-D-13-07647R1
  63. O'Keeffe C, Kabir Z, O'Flaherty M, Walton J, Capewell S, Perry IJ. Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open. 2013 Jul 3;3(7). PubMed PMID: 23824313;
  64. M O’Flaherty, I Buchan, S Capewell. Editorial Review. Contributions Of Treatment And Lifestyle To Declining CVD Mortality: Why have CVD mortality rates declined so much since the 1960s? Heart 2013; 99 (3): 159-62 DOI: 10.1136/heartjnl-2012-302300 PMID: 22962283
  65. T Jørgensen , S Capewell, E Prescott, S Allender, S Sans, T Zdrojewski, et al. Population level changes to promote cardiovascular health. European Journal of Preventive Cardiology 2013; 20 (3): 409-21 PMID 22514213 DOI: 10.1177/2047487312441726
  66. R Ghandour, A Shoaibi, R Khatib,N Abu Rmeileh, B Unal, K Sözmen, B Kılıç,F Fouad, R A Ali, H Ben Romdhane, W Aissi, B Ahmad, S Capewell, J Critchley, A Husseini. Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four Eastern Mediterranean countries. Int J Public Health 2014.
  67. S Bowman; N Unwin; J Critchley; S Capewell; A Husseini; W Maziak; S Zaman; H Ben Romdhane; F Fouad; P Phillimore; B Unal; R Khatib; A Shoaibi; B Ahmad . Promoting the use of evidence to support the development of healthy public policy: a policy effectiveness-feasibility loop. WHO Bulletin 2012. 90 (11): 847-853. DOI: 10.2471/BLT.12.104968
  68. W Maziak, J Critchley, S Zaman, N Unwin, S Capewell, K Bennett, B Unal, A Husseini, H Ben Romdhane, P Phillimore for the MedCHAMPS collaboration. (funded by EU FP7). MEDiterranean studies of Cardiovascular disease and Hyperglycaemia: Analytical Modelling of Population Socio-economic transitions (MedCHAMPS): Rationale and Methods. International J Public H 2012, 58 (4): 547-553. DOI 10.1007/s00038-012-0423-4
  69. E S. Ford, M M. Bergmann, H Boeing, C Li, S Capewell. Healthy lifestyle behaviors and all-cause mortality among adults in the United States Preventive Medicine; 2012; 55: 23-27. PMID: 22564893
  70. Parker M, Lloyd-Williams F, Weston G, McFadden K. Nursery Nutrition in Liverpool: An exploration of practice and nutritional analysis of food provided. Public Health Nutr. 2011 Oct;14(10):1867-75. Epub 2011 May 20.
  71. S Capewell & E Ford. Why Have Total Cholesterol Levels Declined in Most Developed Countries? BMC Public Health 2011, 11:641 doi:10.1186/1471-2458-11-641PMID: 21834954
  72. S Capewell; I Buchan. Why have sustained increases in obesity and type 2 diabetes not offset declines in cardiovascular mortality over recent decades in Western countries? Nutrition Metabolism And Cardiovascular Diseases 2012; 22 (4): 307-311 DOI: 10.1016/j.numecd.2012.01.005 PMID: 22405577
  73. L C Orton, F Lloyd-Williams, D C Taylor-Robinson, M Moonan, M O'Flaherty and S Capewell. Prioritising public health: A qualitative study of decision making to reduce health inequalities. BMC Public Health 2011, 11: 821 doi:10.1186/1471-2458-11-821. PMID: 22014291
  74. F Lloyd-Williams, K Bristow, S Capewell, M Mwatsama. Young children's food in Liverpool day-care settings: a qualitative study of pre-school nutrition policy and practice. Public Health Nutr. 2011; 14 (10):1858-66. Epub 2011 Apr 19. PMID: 21557874
  75. K, Bristow, F Lloyd Williams, K Abba, M Goodall, S Capewell. Healthy eating in early years settings: A review of current national to local guidance for North West England. Public Health Nutrition 2011; 14 (6) : 1008-1016 DOI: 10.1017/S1368980010003836
  76. S Capewell & H Graham. Will cardiovascular disease prevention widen health inequalities? PLoS Medicine 2010; 7(8): e1000320. doi:10.1371/journal.pmed.1000320. PMID: 20811492
  77. S Capewell and D M. Lloyd-Jones. Optimal Cardiovascular Prevention Strategies for the 21st Century. JAMA 2010;304 2057-2058 PMID: 21063015
  78. M Goodall, G R Barton, P Bower, P Byrne, J E Cade, S Capewell, C L Cleghorn, L A Kennedy, A M Martindale, C Roberts, S Woolf, M B Gabbay. Food for thought: pilot randomized controlled trial of lay health trainers supporting dietary change to reduce cardiovascular disease in deprived communities.Journal of Public Health 11/2013; DOI:10.1093/pubmed/fdt112
  79. GR Barton, M Goodall, P Bower, S Woolf, S Capewell, MB Gabbay..Increasing heart-health lifestyles in deprived communities: Economic evaluation of lay health trainers. J Eval in Clinical Practice 2012; 18 (4): 835-840. doi: 10.1111/j.1365-2753.2011.01686.x. PMID: 21518152
  80. L Orton, D Taylor Robinson, M Moonan, M O’Flaherty, S Capewell. The Use of Research Evidence in Public Health Decision Making Processes: Systematic Review PLoS ONE 2011. 6 (7): e21704 PONE-D-11-05641R1 PMID: 21818262 (Top 1% most cited articles in PLoS ONE)
  81. D Taylor Robinson, L Orton, M Moonan, M O’Flaherty, S Capewell. Barriers To Partnership Working In Public Health: A Qualitative Study. PLoS ONE 2012. 7 (1) : e29536 DOI: 10.1371/journal.pone.0029536 PMID: 2238619
  82. S O’Kellie, K Andersen, S Capewell, L Ryden. Bringing prevention to the population: An important role for cardiologists in policy making. Eur Heart J 2011; 32: 1964-1967; doi:10.1093/eurheartj/ehr128. PMID: 21616949
  83. Anon. NICE Public Health Guidance: Prevention of cardiovascular disease at population level. 2010:
  84. K Bristow, S Povall, S Capewell, M Mwatsama, F Lloyd Williams. Exploring health inequalities through the lens of an ethnographic study of healthy eating provision in the early years sector. PMID: 22118155 Maternal & Child Nutrition 2013: 9 (2): 260-273. DOI: 10.1111/j.1740-8709.2011.00359.x
  85. C Law, MP Kelly, E Kaner, PS Meier, S Capewell. Development of public health guidance on the prevention of alcohol misuse and cardiovascular disease: The work of the National Institute for Health and Clinical Excellence, England. Public Health 2012; 126 (3): 230-232 DOI: 10.1016/j.puhe.2011.12.004 PMID: 22325673
  86. S. Capewell. Cardiovascular disease prevention in populations and effects on health inequalities. Report to NICE. 2009
  87. S. Capewell. Prevention of cardiovascular disease at population level: International perspectives. Report to NICE. 2009
  88. S. Capewell. Prevention of cardiovascular disease at population level: Risk factor paradigms and pathways. Report to NICE. 2009
  89. F Cappuccio, S Capewell. Editorial: How to cut down salt intake in populations. Heart 2010;96:1863-1864. doi:10.1136/hrt.2010.209023. PMID: 21062774
  90. Anon. European Chronic Disease Alliance: A Unified Prevention Approach 2010. alliance-Final.pdf
  91. F Cappuccio and S Capewell. A sprinkling of doubt. Excess dietary salt is a killer and you should take any evidence to the contrary . New Scientist 2010.206 (2758): 22-23
  92. S Capewell & K McPherson. Cut junk food, says NICE guidance on cardiovascular disease prevention. Heart 2010 96 1762-3. PMID: 20956493
  93. P Scarborough, K Nnoaham, D Clarke, S Capewell, M Rayner. Modelling the impact of a healthy UK diet on cardiovascular disease and cancer mortality JECH 2012: 66: 420-426. doi:10.1136/jech.2010.114520 PMID: 21172796
  94. M-T Cooney, A Dudina; P Whincup; S Capewell; A Menotti; P Jousilahti; I Njolstad; T Thomsen; R Oganov; A Tversdal; H Wedel; L Wilhelmsen; I Graham. Re-evaluating Rose: Comparative benefits of the population and high risk strategies. Eur J Cardiovasc Prevent Rehabil 2009, 16 (5): 541-549. DOI: 10.1097/HJR.0b013e32832b38a1 PMID: 19773660
  95. Capewell S. BMJ Head to Head. Will screening individuals at high risk of cardiovascular events deliver large benefits? BMJ 2008;337:a1395, doi: 10.1136/bmj.a1395 PMID: 18755771
  96. DC Taylor-Robinson, B Milton, F Lloyd-Williams, M O’Flaherty & S Capewell. Planning ahead in public health? A qualitative study of the time horizons used in public health decision-making. BMC Public Health. 2008, 8:415 PMID: 19094194
  97. Lloyd-Williams F, Birt C, Ireland R, Capewell S. Delivering A Cardiovascular Disease Prevention Programme In The United Kingdom: Translating Theory Into Practice. Eur J Public H 2008 Aug;18(4):357-9. Epub 2008 May 1. PMID: 18450798
  98. Birt C, Maryon-Davis A, Stewart L, Parkin C, Mwatswama M, Capewell S. A CAP on Health. UK Faculty of Public Health. 2008. ISBN: 1-900273-25-X.
  99. F Lloyd-Williams, M Mwatsama, C Birt, R Ireland, S Capewell. Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. WHO Bulletin 2008. 86:535–541. PMID: 18670665 doi: 10.2471/BLT.07.042069
  100. UK Faculty of Public Health. Position statement: Traffic-light food labelling. August 2008. ISBN: 1-900273-35-7
  101. F Lloyd Williams ; M Mwatsama, R Ireland, S Capewell. Small Changes in Snacking Behaviour: the potential impact on cardiovascular disease mortality. Public Health Nutrition 2008; 12(6): 871-876. PMID: 18671888
  102. DC Taylor-Robinson, B Milton, M O’Flaherty, F Lloyd-Williams, S Capewell. Policy-makers’ attitudes to decision support models for coronary disease: a qualitative study." J H Services Res & Policy. 2008 Oct;13(4):209-14.
  103. S Capewell, A Blamey, P Lincoln, M Mwatsama, F Lloyd Williams ; JA Critchley, R Ireland, C Birt, S Platt, N Summerton, C Miller, J Field. Cardiovascular disease prevention at the population level. NICE Potential Public Health Programme Guidance, 2179. 2007. NICE, London.
  104. Critchley JA, Capewell S. Benefits of smoking cessation. Current Cardiovascular Risk Reports 2007; 1 : 360-365.
  105. Capewell S, Lloyd-Williams F, Taylor-Robinson DC. Cardiovascular Disease.BMJ Health Intelligence: 2007 health/topics/content/cardiovascular-diseases/index.html